Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

503 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer.
Lukanova A, Zeleniuch-Jacquotte A, Lundin E, Micheli A, Arslan AA, Rinaldi S, Muti P, Lenner P, Koenig KL, Biessy C, Krogh V, Riboli E, Shore RE, Stattin P, Berrino F, Hallmans G, Toniolo P, Kaaks R. Lukanova A, et al. Among authors: berrino f. Int J Cancer. 2004 Jan 10;108(2):262-8. doi: 10.1002/ijc.11544. Int J Cancer. 2004. PMID: 14639613
Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women.
Lukanova A, Lundin E, Zeleniuch-Jacquotte A, Muti P, Mure A, Rinaldi S, Dossus L, Micheli A, Arslan A, Lenner P, Shore RE, Krogh V, Koenig KL, Riboli E, Berrino F, Hallmans G, Stattin P, Toniolo P, Kaaks R. Lukanova A, et al. Among authors: berrino f. Eur J Endocrinol. 2004 Feb;150(2):161-71. doi: 10.1530/eje.0.1500161. Eur J Endocrinol. 2004. PMID: 14763914 Clinical Trial.
Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study.
Canzian F, McKay JD, Cleveland RJ, Dossus L, Biessy C, Rinaldi S, Landi S, Boillot C, Monnier S, Chajès V, Clavel-Chapelon F, Téhard B, Chang-Claude J, Linseisen J, Lahmann PH, Pischon T, Trichopoulos D, Trichopoulou A, Zilis D, Palli D, Tumino R, Vineis P, Berrino F, Bueno-de-Mesquita HB, van Gils CH, Peeters PH, Pera G, Ardanaz E, Chirlaque MD, Quirós JR, Larrañaga N, Martínez-García C, Allen NE, Key TJ, Bingham SA, Khaw KT, Slimani N, Norat T, Riboli E, Kaaks R. Canzian F, et al. Among authors: berrino f. Br J Cancer. 2006 Jan 30;94(2):299-307. doi: 10.1038/sj.bjc.6602936. Br J Cancer. 2006. PMID: 16404426 Free PMC article.
IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC).
Rinaldi S, Peeters PH, Berrino F, Dossus L, Biessy C, Olsen A, Tjonneland A, Overvad K, Clavel-Chapelon F, Boutron-Ruault MC, Téhard B, Nagel G, Linseisen J, Boeing H, Lahmann PH, Trichopoulou A, Trichopoulos D, Koliva M, Palli D, Panico S, Tumino R, Sacerdote C, van Gils CH, van Noord P, Grobbee DE, Bueno-de-Mesquita HB, Gonzalez CA, Agudo A, Chirlaque MD, Barricarte A, Larrañaga N, Quiros JR, Bingham S, Khaw KT, Key T, Allen NE, Lukanova A, Slimani N, Saracci R, Riboli E, Kaaks R. Rinaldi S, et al. Among authors: berrino f. Endocr Relat Cancer. 2006 Jun;13(2):593-605. doi: 10.1677/erc.1.01150. Endocr Relat Cancer. 2006. PMID: 16728585
Postmenopausal circulating levels of 2- and 16α-hydroxyestrone and risk of endometrial cancer.
Zeleniuch-Jacquotte A, Shore RE, Afanasyeva Y, Lukanova A, Sieri S, Koenig KL, Idahl A, Krogh V, Liu M, Ohlson N, Muti P, Arslan AA, Lenner P, Berrino F, Hallmans G, Toniolo P, Lundin E. Zeleniuch-Jacquotte A, et al. Among authors: berrino f. Br J Cancer. 2011 Oct 25;105(9):1458-64. doi: 10.1038/bjc.2011.381. Epub 2011 Sep 27. Br J Cancer. 2011. PMID: 21952628 Free PMC article.
Circulating levels of insulin-like growth factor-I and risk of ovarian cancer.
Lukanova A, Lundin E, Toniolo P, Micheli A, Akhmedkhanov A, Rinaldi S, Muti P, Lenner P, Biessy C, Krogh V, Zeleniuch-Jacquotte A, Berrino F, Hallmans G, Riboli E, Kaaks R. Lukanova A, et al. Among authors: berrino f. Int J Cancer. 2002 Oct 20;101(6):549-54. doi: 10.1002/ijc.10613. Int J Cancer. 2002. PMID: 12237896
Circulating levels of sex steroid hormones and risk of ovarian cancer.
Lukanova A, Lundin E, Akhmedkhanov A, Micheli A, Rinaldi S, Zeleniuch-Jacquotte A, Lenner P, Muti P, Biessy C, Krogh V, Berrino F, Hallmans G, Riboli E, Kaaks R, Toniolo P. Lukanova A, et al. Among authors: berrino f. Int J Cancer. 2003 May 1;104(5):636-42. doi: 10.1002/ijc.10990. Int J Cancer. 2003. PMID: 12594820
Risk of ovarian cancer in relation to prediagnostic levels of C-peptide, insulin-like growth factor binding proteins-1 and -2 (USA, Sweden, Italy).
Lukanova A, Lundin E, Micheli A, Akhmedkhanov A, Rinaldi S, Muti P, Lenner P, Biessy C, Krogh V, Riboli E, Hallmans G, Berrino F, Zeleniuch-Jacquotte A, Toniolo P, Kaaks R. Lukanova A, et al. Among authors: berrino f. Cancer Causes Control. 2003 Apr;14(3):285-92. doi: 10.1023/a:1023688603547. Cancer Causes Control. 2003. PMID: 12814208
Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women.
Lukanova A, Lundin E, Micheli A, Arslan A, Ferrari P, Rinaldi S, Krogh V, Lenner P, Shore RE, Biessy C, Muti P, Riboli E, Koenig KL, Levitz M, Stattin P, Berrino F, Hallmans G, Kaaks R, Toniolo P, Zeleniuch-Jacquotte A. Lukanova A, et al. Among authors: berrino f. Int J Cancer. 2004 Jan 20;108(3):425-32. doi: 10.1002/ijc.11529. Int J Cancer. 2004. PMID: 14648710
503 results